Key facts
- 73Health’s last known valuation is $5.3M (Jan 2025).
- It has raised $1.1M; the latest was Early Stage VC ($830K) in Jan 2025.
- Notable investors include Innovestor, CVX Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for 73Health
- ·The full record, as it builds
Funding rounds
No funding rounds for 73Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About 73Health
Developer of a remote health examination and telehealth system to improve access to personalized and proactive healthcare. The company's platform integrates telehealth, lab testing, wellness tracking, medical consultations, and digital care coordination, enabling doctors to perform real clinical examinations remotely and help patients seeking accessible and continuous health management with comprehensive tools for preventive care, chronic condition support, and streamlined communication with
- Sector
- Healthcare
- HQ
- Kajaani, Finland
- Founded
- 2022
- Employees
- 3
- Website
- 73health.com/
- Ownership
- Privately Held (backing)
73Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in 73Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on 73Health in its N-PORT filings yet. We sweep new filings monthly.